	Point-of-Care Ultrasound Assessment of Pulmonary and Venous Congestion in Patients with Liver Cirrhosis and Acute Kidney Injury Receiving Albumin: An Exploratory Prospective Study from a Resource-Limited Tertiary Care Center in Western Mexico. Medicina (Kaunas) Rubio-Mora BR, Ochoa-Rodríguez MA, Ambriz-Alarcón MA, Lozano-Sabido EA, Meugniot-García H, Jiménez-Pérez DM, Calleros-Camarena ÁI, Ramírez-Ochoa S, Vicente-Hernández B, Cervantes-Guevara G, Rabago-Solorio E, Cervantes-Perez E. PMID: 42654357 [PubMed - indexed for MEDLINE]
	Therapeutic Targets for Hepatic Fibrosis Driven by Hypoxia-Mediated Hepatic Stellate Cell Activation. Biomolecules Li W, Li T, Mao J. PMID: 42650757 [PubMed - indexed for MEDLINE]
	ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet Gastroenterol Hepatol Loomba R, Wang S, Desai D, Santillano D, Lucas KJ, Neff G, Bianco AC, Bruinstroop E, Su Y, Achneck HE, Le K, Fitzgerald M, Wu M, Lin TI, Chanda SM, Blatt LM, Mantzoros CS. PMID: 42648297 [PubMed - as supplied by publisher]
	Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies. Cells Hayes CM, Cross DR, Achour B, Ghonem NS. PMID: 42645170 [PubMed - indexed for MEDLINE]
	Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial. Aliment Pharmacol Ther Dhaked GK, Sharma PN, Sharma KK, Maharshi S, Agrawal S, Pokharna R, Nijhawan S, Sharma SS. PMID: 42643064 [PubMed - as supplied by publisher]
	Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study. Liver Int Abosheaishaa H, Elfert K, Abusuliman M, Ismail A, Olimy A, Alzamzamy AE, Omran A, Rizzo V, Nassar M, El-Kassas M. PMID: 42642993 [PubMed - indexed for MEDLINE]
	Risk stratification of non-acute decompensation in alcohol-related cirrhosis using the red cell distribution width-to-platelet ratio. Dig Liver Dis Romeo M, Domislovi, Di Nardo F, Napolitano C, Vaia P, Basile C, Mrzljak A, Federico A, Dallio M. PMID: 42642231 [PubMed - as supplied by publisher]
	Association between thyroid feedback quartile index and FIB-4-defined fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, and treated primary hypothyroidism: an exploratory cross-sectional study. Front Endocrinol (Lausanne) Wang Y, Xie J, Wang Y, Liu X, Zhou X. PMID: 42638674 [PubMed - indexed for MEDLINE]
	Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Aliment Pharmacol Ther Gee MFW, Chalfin DB, De Vol EB, Levy HR, Boltyenkov AT, Casale MG, Sanyal AJ. PMID: 42638152 [PubMed - as supplied by publisher]
	Current intervention strategies for collateral circulation formation and splenomegaly in portal hypertension due to cirrhosis. Digestion Sun Y, Zhao Y, Zhao B, Xu Y, Chu H. PMID: 42636178 [PubMed - as supplied by publisher]
	Fibrosis in One-Year Protocol Biopsies After Liver Transplantation Is Associated With Graft Loss: A Multicenter Cohort Study. APMIS Akdag D, Rostved AA, Rasmussen A, Willemoe GL, Chiranth D, Ericzon BG, Jorns C, Bennet W, Nordin A, Åberg F, Hillingsø JG, Nielsen SD, Pommergaard HC. PMID: 42635025 [PubMed - indexed for MEDLINE]
	A Retrospective Analysis of 581 Cases of Esophagogastric Variceal Bleeding Complicated by Portal Vein Thrombosis at a Single Center. Can J Gastroenterol Hepatol Zhang J, He Y, Wu S, Kong D. PMID: 42634416 [PubMed - indexed for MEDLINE]
	Cirrhosis Risk in Sarcoidosis Without Documented Hepatic Involvement-A Large Nationwide Population-Based Cohort Study. Liver Int Shani U, Davidov Y, Zigmond E, Ben-Ami T, Regev O, Cohen AD, Amital H, Ben-Shabat N. PMID: 42631401 [PubMed - indexed for MEDLINE]
	Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. Am J Transl Res Shi L, He X, Hu Y, Rong Y, Xi J. PMID: 42631165 [PubMed]
	[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis. Farm Hosp Rodríguez Esquíroz A, Garjón Parra J, Echeverría Gorriti A, Sanz Álvarez L, Marín Marín M, Aguinaga Ontoso I. PMID: 42629217 [PubMed - as supplied by publisher]
	Carvedilol Continues to Win: A Target Trial Emulation Study Comparing Carvedilol Against Other Nonselective B-Blockers in Cirrhosis. Gastroenterology Liu A. PMID: 42628812 [PubMed - as supplied by publisher]
	Aspects of implementing a nurse-based follow-up of patients with liver cirrhosis: A qualitative study. PLoS One Hjorth M, Forsberg A. PMID: 42627780 [PubMed - indexed for MEDLINE]
	Intrahepatic Platelets Orchestrate Microenvironmental Remodelling and Cellular Crosstalk in Liver Fibrosis. Liver Int Chen Z, Li H, Ji Q, Gao R, Zhang W, Wu W, Pan Z, Ma H, Wang C, You H, Chen W. PMID: 42627112 [PubMed - indexed for MEDLINE]
	Decoding fibroblast activation: Transcriptional networks in hepatic stellate cells and across fibrotic organs (Review). Int J Mol Med Charoenthanakitkul D, Ariyachet C. PMID: 42627051 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Revisiting salt restriction in hyponatremic cirrhosis - a paradigm in need of refinement? World J Methodol Zou CL. PMID: 42626170 [PubMed]

Articles 1 - 20 / 39177

Page 1 of 1959



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy